BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16504343)

  • 1. Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease.
    Reix S; Mechawar N; Susin SA; Quirion R; Krantic S
    Neurobiol Aging; 2007 Mar; 28(3):351-6. PubMed ID: 16504343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease.
    Yu W; Bonnet M; Farso M; Ma K; Chabot JG; Martin E; Torriglia A; Guan Z; McLaurin J; Quirion R; Krantic S
    BMC Neurosci; 2014 Jun; 15():73. PubMed ID: 24915960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of apoptosis-inducing factor (AIF) in the aged rat brain.
    Yu W; Gubkina O; Mechawar N; Elwell D; Quirion R; Krantic S
    Neurobiol Aging; 2011 Jan; 32(1):179-80. PubMed ID: 19251341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease.
    Yu W; Mechawar N; Krantic S; Quirion R
    Am J Pathol; 2010 May; 176(5):2209-18. PubMed ID: 20228227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of apoptosis-inducing factor translocation is a possible mechanism for protective effects of hepatocyte growth factor against neuronal cell death in the hippocampus after transient forebrain ischemia.
    Niimura M; Takagi N; Takagi K; Mizutani R; Ishihara N; Matsumoto K; Funakoshi H; Nakamura T; Takeo S
    J Cereb Blood Flow Metab; 2006 Nov; 26(11):1354-65. PubMed ID: 16511502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
    Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
    Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease.
    Ishunina TA; Fischer DF; Swaab DF
    Neurobiol Aging; 2007 Nov; 28(11):1670-81. PubMed ID: 17010478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of AIF expression by p53.
    Stambolsky P; Weisz L; Shats I; Klein Y; Goldfinger N; Oren M; Rotter V
    Cell Death Differ; 2006 Dec; 13(12):2140-9. PubMed ID: 16729031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
    Hellström-Lindahl E; Ravid R; Nordberg A
    Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis-inducing factor: a matter of neuron life and death.
    Krantic S; Mechawar N; Reix S; Quirion R
    Prog Neurobiol; 2007 Feb; 81(3):179-96. PubMed ID: 17267093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.
    Frisoni GB; Ganzola R; Canu E; Rüb U; Pizzini FB; Alessandrini F; Zoccatelli G; Beltramello A; Caltagirone C; Thompson PM
    Brain; 2008 Dec; 131(Pt 12):3266-76. PubMed ID: 18988639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early complement activation increases in the brain in some aged normal subjects.
    Loeffler DA; Camp DM; Schonberger MB; Singer DJ; LeWitt PA
    Neurobiol Aging; 2004 Sep; 25(8):1001-7. PubMed ID: 15212824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in caspase expression in Alzheimer's disease: comparison with development and aging.
    Shimohama S; Tanino H; Fujimoto S
    Biochem Biophys Res Commun; 1999 Mar; 256(2):381-4. PubMed ID: 10079193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs.
    Zhang GR; Cheng XR; Zhou WX; Zhang YX
    Neuroscience; 2009 Mar; 159(1):308-15. PubMed ID: 18721865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
    Lorenzo HK; Susin SA
    Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular environment facilitates protein accumulation in aged rat hippocampus.
    Paz Gavilán M; Vela J; Castaño A; Ramos B; del Río JC; Vitorica J; Ruano D
    Neurobiol Aging; 2006 Jul; 27(7):973-82. PubMed ID: 15964666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The entorhinal cortex (hippocampal formation) in aging and Alzheimer's disease. Neuroanatomical interpretation].
    Sobreviela T; Insausti A; Salinas A; Gonzalo LM; Insausti R
    Rev Med Univ Navarra; 1997; 41(1):19-27. PubMed ID: 9527711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral imaging in healthy aging: contrast with Alzheimer disease].
    Desgranges B; Kalpouzos G; Eustache F
    Rev Neurol (Paris); 2008 May; 164 Suppl 3():S102-7. PubMed ID: 18675034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
    Wang J; Xiong S; Xie C; Markesbery WR; Lovell MA
    J Neurochem; 2005 May; 93(4):953-62. PubMed ID: 15857398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.